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Introduction
The development of a real-time intraoperative detection sys-
tem that is sensitive and specific for tumors will help ensure 
complete tumor resection, as a clear boundary between 
tumor and normal tissues is ideal for real-time surgical 
imaging, particularly for tiny (<5 mm) liver metastases and 
superficial liver tumors that cannot be observed before sur-
gery (van der Vorst et al. 2012). Although sensitive optical 
sensors and probes have been developed, including nano-
particles, fluorescent proteins, or near-infrared (NIR) fluo-
rescent molecules, time is necessitated for these entities to 
be used routinely in clinical practice (de Chermont et al. 
2007; Adusumilli et al. 2006; Veiseh et al. 2007).
As a surgical navigation technology, an indocyanine green 
(ICG) fluorescence imaging (FI) system has had a posi-
tive effect on the surgical treatment of gastric cancer, breast 
cancer, and skin cancer, as well as other tumors (Miyashiro 
et al. 2008; Kitai et al. 2005; Tsujino et al. 2009; Kurihara 
et al. 2015; Morita et al. 2013). Further, ICG is used in liver 
function tests and accumulates in hepatocellular carcinoma 
(HCC) tissues postintravenous injection (Shibasaki et al. 
2015). In 2009, Ishizawa et al. reported the first applica-
tion an ICG–FI navigation system in the surgical treatment 
of liver tumors (Lim et al. 2014). Moreover, ICG is a rela-
tively safe reagent that is clinically approved by the United 
States Food and Drug Administration (FDA) for examina-
tion of hepatic function, cardiac output, and retinal angi-
ography and has been used for these purposes for 20 years 
(Lim et al. 2014; Kitai et al. 1999). Given that ICG is already 
used in clinical imaging examinations, the use of ICG in 
Abstract 
Purpose Clear delineation between tumors and normal tis-
sues is ideal for real-time surgical navigation imaging. We 
investigated applying indocyanine green (ICG) fluores-
cence imaging navigation using an intraoperative adminis-
tration method in liver resection.
Methods Fifty patients who underwent liver resection 
were divided into two groups based on clinical situation 
and operative purpose. In group I, sizes of superficial liver 
tumors were determined; tiny tumors were identified. In 
group II, the liver resection margin was determined; real-
time navigation was performed. ICG was injected intrave-
nously at the beginning of the operation; the liver surface 
was observed with a photodynamic eye (PDE).
Results Liver resection margins were determined using 
PDE. Fluorescence contrast between normal liver and 
tumor tissues was obvious in 32 of 35 patients. A boundary 
for half the liver or specific liver segments was determined 
in nine patients by examining the portal vein anatomy after 
ICG injection. Eight small tumors not observed preopera-
tively were detected; the smallest was 2 mm.
Conclusions ICG fluorescence imaging navigation is a 
promising, simple, and safe tool for routine real-time intra-
operative imaging during hepatic resection and clinical 
exploration in hepatocellular carcinoma, enabling high sen-
sibility for identifying liver resection margins and detecting 
tiny superficial tumors.
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intraoperative imaging may help improve the accuracy of 
tumor and liver tissue demarcation and identification.
In the present study, we introduced an efficient ICG–FI 
system that allows for accurate navigation during liver resec-
tion using an intraoperative ICG delivery method in China.
Materials and methods
This study was approved by the Institutional Review Board 
of the Tianjin First Central Hospital.
Research objective
Fifty patients underwent liver resection between Sep 2014 
and May 2015 at Tianjin First Central Hospital. The pres-
ence of focal liver lesions was confirmed with abdominal 
ultrasound, enhanced computed tomography (CT), or mag-
netic resonance imaging (MRI), and distant involvement 
and metastases were ruled out. Liver function was assessed 
to determine the Child-Pugh score, and an ICG skin test 
was performed before surgery.
According to the actual tumor status and operative goal, 
patients were divided into two groups: group I, determination 
of the range in size of superficial tumors and identification of 
a small tumor; and group II, determination of a liver resection 
margin and real-time navigation during a liver resection.
Patient inclusion criteria
To be enrolled in this study, patients had to meet the following 
criteria: confirmed lesion occupying the liver using abdomi-
nal ultrasound, abdominal CT scan, and MRI plus four-phase 
CT imaging before surgery; exclusion of distant involvement 
and metastasis; Child A liver function during a preoperative 
assessment; did not have embolization treatment before sur-
gery; and negative ICG skin test before surgery.
Experimental reagents and equipment
In this study, we used an ICG injection (Dandong Medical 
and Pharmaceutical Co, Ltd). According to the manufactur-
er’s instructions for the ICG solution, it was used at a con-
centration of 2.5 mg/ml, and light exposure was avoided. 
Further, a photodynamic eye (PDE, Hamamatsu Photonics 
Trading Co, Ltd) was used.
Research methods
In this study, we had a group comprising patients who under-
went the following: determination of the range in size of liver 
superficial tumors and identification of small tumors. For 
the ICG procedures, we used the following technique. First, 
an intravenous injection of ICG at a 0.25-mg/kg dose was 
administered during surgery through the following routes: 
(1) portal vein puncture; (2) right vein of the stomach; and 
(3) central venous catheter. Second, an infrared fluorescence 
observation camera was turned on, using the imaging mode 
on the camera. Third, we adjusted the brightness, contrast, 
and sharpness of the photon eye. Fourth, a surgeon used a 
satirized package of lenses and cables for the photon eye. 
Fifth, the surgeon irradiated the liver with the photon eye at 
a distance of 5–10 cm above the liver surface. Lastly, PDE 
equipment was used to directly examine the liver, so the liver 
cancer could be detected; subsequently, the cutting edge of 
the liver could be confirmed. After surgery, the specimens 
were sent to pathology, and the intraoperative observations 
were compared with the pathological findings of the liver.
In this study, we had a second group that underwent 
the following: determination of hepatic resection margin 
and real-time navigation during a hepatectomy. To do so, 
the following procedures were performed. (1) The precut 
half of the liver was marked using the following methods: 
Intraoperatively, the hepatic portal vein was dissected to 
free it, along with its left and right branches. The portal 
vein branches in the resected liver were ligated. ICG was 
infused at a dose of 0.25 mg/kg through a central venous 
catheter. PDE was used to clearly observe the line at which 
the liver would be cut in half. Then, the liver resection line 
was marked in the PDE approach guide.
We used the following methods to mark a standard cut 
segment of the liver. According to the preoperative imag-
ing findings, the left and/or right pedicle of the liver was 
dissected and freed intraoperatively. Then, the liver paren-
chyma was removed using Cut-ultrasound aspiration 
(CUSA), and the Glisson’s sheath of the segments or sub-
segments was fully visualized. The portal vein was freed, 
and the distal portal vein on the precut side was clamped. 
After injection of 1–2 mg of ICG through the puncture site 
and release of the vessel clip, PDE allowed for the clear 
observation of the status of the liver segment and was used 
to determine the hepatectomy line.
Results
Characteristics of the study subjects
A total of 50 patients were included in this study, with 30 
men and 20 women, and their mean age was 54.18 years. 
There were 16 (32 %) patients aged 40–50 years, 21 (42 %) 
patients aged 50–60 years, and 13 (26 %) patients aged 
60–75 years. The enrolled patients had the following char-
acteristics: 38 had hepatitis B, and 5 had hepatitis C.
There were 35 (70 %) patients in group I (small tumors 
group; determination of the range in size of superficial 
53J Cancer Res Clin Oncol (2017) 143:51–58 
1 3
tumors and identification) and 15 (30 %) in group II (liver 
resection group; determination of the liver resection margin 
and real-time navigation) (Table 1).
The patients had the following tumor sizes: ≤3 cm in 6 
patients, >2 cm and ≤5 cm in 16 patients, and >5 cm in 28 
patients. As for tumor position, the tumor was confined to 1 
hepatic segment in 7 (14 %) patients, involved 2 liver seg-
ments in 16 (32 %) patients, and involved more than 2 liver 
segments in 27 (54 %) patients. Regarding the overall post-
operative pathology, 38 (76 %) patients had hepatocellular 
carcinoma, 4 (8 %) patients had a cavernous hemangioma, 
3 (6 %) patients had a cholangiocarcinoma, 2 (4 %) patients 
had colon cancer with liver metastases, 1 (2 %) patient had 
a malignant fibrous histiocytoma, and 2 (4 %) patients had 
micronodular cirrhosis (Table 1).
Effects of different ICG administration routes on liver 
FI with PDE
With an ICG injection through the portal vein or right vein 
of the stomach, fluorescence of the normal liver developed 
rapidly within 1–2 min, while fluorescence of the cirrhotic 
tissue developed slowly and was not uniform (Fig. 1). With 
an ICG injection through the central venous catheter, flu-
orescence of the normal liver developed in 5–10 min and 
was uniform, and the fluorescence pattern observed with 
this route of administration was not different from that 
observed with administration through the portal vein or the 
right vein of the stomach.
Effects of intraoperative administration method 
on liver tumor fluorescence imaging under PDE
After administration of the drug, tumors appeared as a 
shadow with a PDE, as compared with normal liver tissues. 
This difference was obvious; the fluorescence pattern was 
consistent; and no differences existed in the fluorescence 
patterns between benign and malignant tumors (Figs. 2, 3, 
4). The postoperative pathological findings were as follows: 
HCC (23 patients), micronodular cirrhosis (2 patients), 
cavernous hemangioma (4 patients), malignant fibrous his-
tiocytoma (1 patient), cholangiocarcinoma (3 patients), and 
colon cancer with liver metastasis (2 patients). The margins 
of all liver resection specimens were negative.
Identification of small liver tumors with fluorescence 
imaging with a PDE
With the use of an intraoperative PDE, we found 12 small 
tumors in 8 patients in whom a preoperative imaging 
examination did not reveal the existence of these tumors. 
The postoperative pathological findings were as follows: 
hepatocellular carcinoma (five patients), recurrent nodu-
lar cirrhosis (two patients), liver macrovesicular steatosis 
(one patient), hemangioma (two patients), and hepatic focal 
hyperplasia (two patients). The smallest lesion was approx-
imately 2 mm in diameter (Fig. 5).
Determination of the liver resection margin or 
hemihepatectomy line using FI with a PDE
Five to 10 min after an ICG injection through a central venous 
catheter, hemihepatic fluorescence of the precut side was 
observed, and the hemihepatectomy line was seen clearly and 
accurately with a PDE. The liver was cut along this line, and 
the line was monitored with a PDE during surgery to allow 
the direction of cutting to be altered if necessary (Fig. 6).
Discussion
In the present study, using an intraoperative administration 
of ICG with an FI navigation system and a PDE, we found 
12 small tumors in 8 patients in whom a preoperative imag-
ing examination did not indicate that these tumors existed. 
Table 1  Characteristics of study subjects
Variables in Table 1 are shown as counts and percentages
Group I: determination of ranges in size of superficial tumors and 
identification of small tumors
Group II: determination of liver resection margin and real-time navi-
gation in liver resection
N %
Age
 40–50 16 32.0
 50–60 21 42.0
 60–75 13 26.0
Sex
 Male 30 60.0
 Female 20 40.0
Tumor position
 1 hepatic segment 7 14.0
 2 hepatic segments 16 32.0
 >2 hepatic segments 27 54.0
Postoperative pathology
 Hepatocellular carcinoma 38 76.0
 Cavernous hemangioma 4 8.0
 Cholangiocarcinoma 3 6.0
 Colon cancer with liver metastasis 2 4.0
 Malignant fibrous histiocytoma 1 2.0
 Micronodular cirrhosis 2 4.0
Group
 Group I 35 70.0
 Group II 15 30.0
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Of these eight patients, five patients had hepatocellular car-
cinoma; we also found the following conditions: recurrent 
nodular cirrhosis (two patients), liver macrovesicular stea-
tosis (two patient), hemangioma (two patients), and hepatic 
focal hyperplasia (two patients). With our intraoperative 
ICG–FI navigation system, the smallest detected tumors 
were approximately 2 mm in diameter.
ICG is an FDA-approved reagent that is safe for examina-
tion of hepatic function, cardiac output, and retinal angiogra-
phy (Lim et al. 2014; Kitai et al. 1999). ICG is a near-infra-
red fluorescent dye that is stimulated by light wavelengths 
of 750–810 nm that produce near-infrared light with a wave-
length of 850 nm (Porcu et al. 2016). Near-infrared light can 
be observed using an ICG–FI system with a PDE and is dis-
played with the help of a developing device (van der Vorst 
et al. 2012; Porcu et al. 2016; Abo et al. 2015).
ICG fluorescence can penetrate living tissue deeply 
and thus can be advantageous for visualizing these tissues 
(Gotoh et al. 2009). In a preliminary study, Kitai et al. 
reported that fluorescence was observed from an ICG solu-
tion embedded 1 cm deep in material with optical proper-
ties compatible with human tissues; after an intravenous 
injection of ICG, it was rapidly ingested by the liver, as 
indicated by the stimulation of emission light (Miyashiro 
et al. 2008). To that end, after several hours, the liver can 
completely excrete ICG, and the fluorescence gradually 
dissipates (de Graaf et al. 2011). However, in cases of liver 
cirrhosis, liver regeneration nodules, liver cancer, and other 
types of liver dysfunction, the secretion and excretion func-
tion of liver cells is impaired, and ICG remains in lesions; 
thus, the dissipation of fluorescence is delayed (Gotoh et al. 
2009; de Graaf et al. 2011; van der Vorst et al. 2013).
ICG–FI is a safe and minimally invasive technique 
(Gotoh et al. 2009). Several studies have reported that an 
intravenous ICG administration of 0.25–0.5 mg/kg from 
12–24 h to 14 days before surgery helps to identify tumors 
Fig. 1  Differences in imag-
ing findings between a normal 
liver and cirrhotic liver with 
a photodynamic eye after the 
intraoperative administration of 
indocyanine green. Normal liver 
(a); normal liver with uniform 
fluorescence as seen with a 
photodynamic eye (b); cirrhotic 
liver (c); cirrhotic liver with 
uneven fluorescence as seen 
with a photodynamic eye (d)
Fig. 2  Changes to the liver 
after being suppressed by a 
tumor as seen with a photo-
dynamic eye. A patient with a 
diaphragmatic tumor exerting 
downward pressure on the liver 
with no invasion (a), the liver 
under pressure as visualized 
with a photodynamic eye (b)
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with clear boundaries with intraoperative FI (Tsujino et al. 
2009; Morita et al. 2013; Lim et al. 2014; Kawaguchi et al. 
2013). In a report by Kawaguchi et al., an 81-year-old man 
with recurrent HCC secondary to hepatitis C was adminis-
tered an ICG injection 4 days prior to surgery that revealed 
clear fluorescence of the tumor on the liver surface during 
surgery (Kawaguchi et al. 2013). In the present study, fluo-
rescence contrast between normal liver and tumor tissues 
was obvious in 32 of 35 patients with intraoperative ICG 
administration. A boundary for half the liver or specific 
liver segments was determined in nine patients by examin-
ing the portal vein anatomy after ICG injection.
At present, the mechanisms that mediate the accumula-
tion of ICG in HCC nodules relative to normal liver tissue 
remain unknown. Normal liver tissue can rapidly uptake 
ICG, and ICG is usually eliminated in bile; however, 
severely cirrhotic liver tissue may not be able to elimi-
nate ICG (Sear 1990; Verbeek et al. 2012). In contrast, it 
has been shown that ICG passively accumulates in HCC if 
ICG is administered 1–8 days prior to surgery; therefore, 
borders of superficial liver tumors can be visualized clearly 
and accurately with a PDE (Verbeek et al. 2012). Using this 
principle, a boundary of a tumor can be determined that can 
aid in the determination of the liver resection line.
Three intraoperative routes of administration of ICG 
were clinically validated in this study. Administering ICG 
into the portal vein or right vein of the stomach, fluores-
cence of normal liver tissue developed within 1–2 min, 
while fluorescence of the cirrhotic tissue developed slowly 
and non-uniformly. However, administering ICG through 
a central venous catheter, fluorescence of normal liver tis-
sue developed uniformly in 5–10 min, but the fluorescence 
pattern observed with this route of administration did not 
differ from that observed with administration through the 
portal vein or right vein of the stomach. Moreover, central 
venous ICG administration resulted in slightly slower and 
weaker fluorescence, but with an increased dose, the results 
significantly improved. We observed that central venous 
Fig. 3  Intraoperative indocya-
nine green administration for 
visualization of liver metastases 
with a photodynamic eye. Pre-
operative computed tomography 
showing colon cancer with liver 
metastasis in the right lobe (a), 
pathologic diagnosis of colon 
cancer metastasis (b), visible 
liver tumor during surgery (c), 
no tumor development visual-
ized with a photodynamic eye, 
and the boundaries between the 
tumor and normal liver were 
clear (d), surgical resection 
specimens (e), inspection of 
specimen with a photodynamic 
eye (f)
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administration avoided the anatomy of the portal hepatic 
and right gastroepiploic veins, shortening the operative 
time and reducing injuries.
An ICG fluorescent system has the ability to detect 
small lesions that preoperative imaging examinations can-
not help identify (van der Vorst et al. 2012). Preoperative 
imaging examinations such as CT and ultrasound have lim-
ited detection rates for small tumors in the liver (van der 
Vorst et al. 2012). Even with intraoperative ultrasounds, 
tiny lesions on the liver surface can be easily missed, lead-
ing to the occurrence of liver metastasis in the short term. 
With preoperative ICG administration, it can be difficult to 
detect a demarcation line in the liver parenchyma, as cir-
rhotic liver nodules have the same appearance as tumor 
tissues (Kurihara et al. 2015). At this time, one negative is 
that malignant tumors cannot be distinguished from benign 
tumors, thus leading to a high false positive rate (Morita 
et al. 2013). In this study combining ICG imaging with the 
use of a PDE, eight patients had small tumors that were 
not identified during a preoperative imaging examination, 
including five patients who had malignant lesions.
Because of more accurate preoperative imaging assess-
ments and intraoperative real-time three-dimensional navi-
gation instructions, liver resection has become more accu-
rate (Morise et al. 2014). It can also be used repeatedly, 
avoiding the disadvantages of repetitive dyeing of the liver 
with methylene blue (Ishizawa et al. 2012; Ishizawa and 
Kokudo 2013; Lim and Vibert 2013).
This study had some limitations. First, this study had a 
small sample size. Additional investigation with a larger 
sample size is necessitated to demonstrate these results. 
Second, this study did not compare the results demon-
strated in the two groups with those of a comparator group. 
Third, this study did not compare the current results with 
those of prior studies. Therefore, future study is needed 
to compare preoperative ICG injection timing and various 
routes of ICG administration and to further apply this tool 
in clinical practice.
Fig. 4  Intraoperative indocya-
nine green administration for 
visualization of hepatocellular 
carcinoma with a photodynamic 
eye. Preoperative magnetic 
resonance imaging showing 
liver cancer in the right lobe (a), 
pathologic diagnosis of hepa-
tocellular carcinoma (b), tumor 
viewed intraoperatively (c), 
no tumor development along 
with clear tumor boundaries, as 
visualized with a photodynamic 
eye (d), after surgery, cutting 
the specimen revealed that the 
excised tumor had a complete 
capsule (e), inspection of a sec-
tion with a photodynamic eye 
revealed no tumor development 
(f), there was visible fluores-
cence surrounding the normal 
liver tissue, demonstrating 
that the tumor tissue cannot 
quickly absorb indocyanine 
green, showing intraoperative 
fluorescence
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Fig. 5  Application of a pho-
todynamic eye for identifying 
tiny tumors with intraoperative 
indocyanine green administra-
tion. Preoperative computed 
tomography showing a visible 
VII segment of a liver tumor, 
and the other segments had no 
obvious small tumor foci (a), 
intraoperative photodynamic 
eye examination of the liver; 
in addition to known tumors, a 
4-mm diameter shadow nodule 
was visible (b), tumor nodules 
were found on the liver surface 
and sent for pathological 
analysis (c), pathological results 
confirming hepatocellular carci-
noma (d)
Fig. 6  Semi-hepatectomy with the assistance of a photodynamic eye. 
After ligation of the right hepatic artery and right back branch of the 
portal vein, the right hepatic ischemia line was not obvious (a); after 
administering indocyanine green, fluorescence rapidly developed in 
the left hepatic lobe, and visualization with the photodynamic eye 
clearly and accurately revealed the hepatectomy line (b). Then, the 
liver was split along that line; the liver during the splitting process 
(c). A photodynamic eye can be used at any time to observe the cut-
ting route so it can be adjusted if necessary; resection of one-half of 
the liver is complete (d); examination of the liver sections with the 
photodynamic eye, the remaining liver showed full fluorescence, 
indicating that the resection met the requirements of complete semi-
hepatectomy
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Conclusion
The current findings indicate that an ICG–FI naviga-
tion technology is a new real-time intraoperative imaging 
method. This technique is promising for hepatic resection 
and clinical exploration in HCC. Our study demonstrated 
that intraoperative ICG–FI navigation enables the iden-
tification of small and grossly unidentifiable liver cancer 
tumors in real time, enhancing the accuracy of liver resec-
tion and operative cancer staging.
Compliance with ethical standards 
Conflict of interest None declared.
Ethical approval This study was approved by the Institutional 
Review Board of the Tianjin First Central Hospital.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution 4.0 International License (http://crea-
tivecommons.org/licenses/by/4.0/), which permits unrestricted use, 
distribution, and reproduction in any medium, provided you give 
appropriate credit to the original author(s) and the source, provide a 
link to the Creative Commons license, and indicate if changes were 
made.
References
Abo T, Nanashima A, Tobinaga S, Hidaka S, Taura N, Takagi K, Arai 
J, Miyaaki H, Shibata H, Nagayasu T (2015) Usefulness of intra-
operative diagnosis of hepatic tumors located at the liver surface 
and hepatic segmental visualization using indocyanine green-
photodynamic eye imaging. Eur J Surg Oncol 41(2):257–264
Adusumilli PS, Stiles BM, Chan MK, Eisenberg DP, Yu Z, Stanziale 
SF, Huq R, Wong RJ, Rusch VW, Fong Y (2006) Real-time diag-
nostic imaging of tumors and metastases by use of a replication-
competent herpes vector to facilitate minimally invasive onco-
logical surgery. FASEB J 20:726–728
de Chermont QLM, Chaneac C, Seguin J, Pellé F, Maîtrejean S, Jol-
ivet JP, Gourier D, Bessodes M, Scherman D (2007) Nanoprobes 
with near-infrared persistent luminescence for in vivo imaging. 
Proc Natl Acad Sci USA 104:9266–9271
de Graaf W, Häusler S, Heger M, van Ginhoven TM, van Cappellen 
G, Bennink RJ, Kullak-Ublick GA, Hesselmann R, van Gulik 
TM, Stieger B (2011) Transporters involved in the hepatic uptake 
of (99 m)Tc-mebrofenin and indocyanine green. J Hepatol 
54(4):738–745
Gotoh K, Yamada T, Ishikawa O, Takahashi H, Eguchi H, Yano M, 
Ohigashi H, Tomita Y, Miyamoto Y, Imaoka S (2009) A novel 
image-guided surgery of hepatocellular carcinoma by indo-
cyanine green fluorescence imaging navigation. J Surg Oncol 
100(1):75–79
Ishizawa T, Kokudo N (2013) Identification of hepatocellular carci-
noma. Fluoresc Imaging 31:10–17
Ishizawa T, Zuker NB, Kokudo N, Gayet B (2012) Positive and nega-
tive staining of hepatic segments by use of fluorescent imag-
ing techniques during laparoseopichepateetomy. Arch Surg 
147(4):393–394
Kawaguchi Y, Aoki T, Ishizawa T, Arita J, Satou S, Kaneko J, Saka-
moto Y, Sugawara Y, Hasegawa K, Kokudo N (2013) Education 
and imaging: hepatobiliary and pancreatic: identification of 
recurrent hepatocellular carcinoma by intraoperative fluorescent 
imaging. J Gastroenterol Hepatol 28(3):587
Kitai T, Miwa M, Liu H, Beauvoit B, Chance B, Yamaoka Y (1999) 
Application of near-infrared time resolved spectroscopy to rat 
liver—a preliminary report for surgical application. Phys Med 
Biol 44:2049–2061
Kitai T, Inomoto T, Miwa M, Shikayama T (2005) Fluorescence 
navigation with indocyanine green for detecting sentinel lymph 
nodes in breast cancer. Breast Cancer 12:211–215
Kurihara T, Yamashita Y, Yoshida Y, Takeishi K, Itoh S, Harimoto N, 
Yoshizumi T, Shirabe K, Ikeda T, Maehara Y (2015) Indocya-
nine green fluorescent imaging for hepatic resection of the right 
hepatic vein drainage area. J Am Coll Surg 221(3):e49–e53
Lim C, Vibert E (2013) Identification of metastatic liver cancer. Fluo-
resc Imaging 31:18–24
Lim C, Vibert E, Azoulay D, Salloum C, Ishizawa T, Yoshioka R, 
Mise Y, Sakamoto Y, Aoki T, Sugawara Y et al (2014) Indocya-
nine green fluorescence imaging in the surgical management of 
liver cancers: current facts and future implications. J Visc Surg 
151(2):117–124
Miyashiro I, Miyoshi N, Hiratsuka M, Kishi K, Yamada T, Ohue M, 
Ohigashi H, Yano M, Ishikawa O, Imaoka S (2008) Detection of 
sentinel node in gastric cancer surgery by indocyanine green flu-
orescence imaging: comparison with infrared imaging. Ann Surg 
Oncol 15:1640–1643
Morise Z, Kawabe N, Tomishige H, Nagata H, Kawase J, Arakawa S, 
Yoshida R, Isetani M (2014) Recent advances in liver resection 
for hepatocellular carcinoma. Front Surg 1(21):1–8
Morita Y, Sakaguchi T, Unno N, Shibasaki Y, Suzuki A, Fukumoto K, 
Inaba K, Baba S, Takehara Y, Suzuki S, Konno H (2013) Detec-
tion of hepatocellular carcinomas with near-infrared fluorescence 
imaging using indocyanine green: its usefulness and limitation. 
Int J Oncol 18:232–241
Porcu EP, Salis A, Gavini E, Rassu G, Maestri M, Giunchedi P (2016) 
Indocyanine green delivery systems for tumour detection and 
treatments. Biotechnol Adv 34(5):768–789
Sear JW (1990) Hepatic physiology. Curr Anaesth Crit Care 
1(4):196–203
Shibasaki Y, Sakaguchi T, Hiraide T, Morita Y, Suzuki A, Baba S, 
Setou M, Konno H (2015) Expression of indocyanine green-
related transporters in hepatocellular carcinoma. J Surg Res 
193(2):567–576
Tsujino Y, Mizumoto K, Matsuzaka Y, Niihara H, Morita E (2009) 
Fluorescence navigation with indocyanine green for detecting 
sentinel nodes in extramammary Paget’s disease and squamous 
cell carcinoma. J Dermatol 36:90–94
van der Vorst JR, Hutteman M, Mieog JS, de Rooij KE, Kaijzel EL, 
Löwik CW, Putter H, Kuppen PJ, Frangioni JV, van de Velde 
CJ, Vahrmeijer AL (2012) Near-infrared fluorescence imaging 
of liver metastases in rats using indocyanine green. J Surg Res 
174(2):266–271
van der Vorst JR, Schaafsma BE, Hutteman M, Verbeek FP, Lief-
ers GJ, Hartgrink HH, Smit VT, Löwik CW, van de Velde CJ, 
Frangioni JV, Vahrmeijer AL (2013) Near infrared fluores-
cence guided resection of colorectal liver metastases. Cancer 
119(18):3411–3418
Veiseh M, Gabikian P, Bahrami SB, Veiseh O, Zhang M, Hackman 
RC, Ravanpay AC, Stroud MR, Kusuma Y, Hansen SJ et al 
(2007) Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intra-
operative visualization of cancer foci. Cancer Res 67:6882–6888
Verbeek FP, van der Vorst JR, Schaafsma BE et al (2012) Image-
guided cancer surgery: the value of near-infrared fluorescence 
imaging during oncologic and gastrointestinal procedures. J 
Hepatobiliary Pancreat Sci 19(6):626–637
